openPR Logo
Press release

Chemotherapy Induced Peripheral Neuropathy Treatment Market: Size, Growth, Key Players, and Trends through 2025 to 2029

01-27-2025 06:11 AM CET | Health & Medicine

Press release from: The Business Research Company

Chemotherapy Induced Peripheral Neuropathy Treatment Market

Chemotherapy Induced Peripheral Neuropathy Treatment Market

"
CAGR, market size, and key players are driving the global Chemotherapy Induced Peripheral Neuropathy Treatment market's growth, with significant CAGR projected through 2029.

What Is The Projected Market Size Of The Global Chemotherapy Induced Peripheral Neuropathy Treatment Market And Its Growth Rate?
Based on recent and projected growth data, we can outline the following key statistics:
• The market size is expected to increase from $1.66 billion in 2024 to $1.78 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.1%.
• By 2029, the market size is projected to reach $2.5 billion, signifying a CAGR of 8.9%.
• The historic growth can be attributed to advancements in chemotherapy and cancer treatment, as well as the rising incidence of cancer.
• Looking ahead, trends such as targeted therapies, development of neuroprotective agents, and integrated care pathways will drive market growth.

What Is Driving The Growth In The Chemotherapy Induced Peripheral Neuropathy Treatment Market?
Increasing prevalence of cancer is one of the key drivers of the market growth. Given the uncontrolled growth and spread of abnormal cells in the body, chemotherapy-induced peripheral neuropathy often results as a side effect. The increase in cancer cases worldwide inevitably leads to the growth of the chemotherapy-induced peripheral neuropathy treatment market. For instance, it was reported by the American Cancer Society that the estimated new cases of liver cancer in females diagnosed in the United States increased from 12,660 in 2022 to 13,230 in 2023. This increase underlines the growing requirement for such treatments.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11967&type=smp

Who Are the Key Players Driving Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth?
Key players in the market include:
• Hoffmann-La Roche Ltd.
• Midatech Pharma PLC
• Novartis AG
• Lee's Pharmaceutical Holdings Limited
• RELIEF THERAPEUTICS Holding SA
• Eurofins Advinus
• WEX Pharmaceuticals Inc.
• Asahi Kasei Corporation
• MediciNova Inc.
• Solasia Pharma K.K.

What Are The Key Trends In The Chemotherapy Induced Peripheral Neuropathy Treatment Market?
The forecast period is expected to see the following major trends:
• Development of novel drug formulations.
• Utilization of non-pharmacological interventions.
• Exploration of neuroplasticity-based therapies.
• Support for long-term survivorship.
• Adoption of cognitive behavioral therapies.

What Are The Segments Of The Global Chemotherapy Induced Peripheral Neuropathy Treatment Market?
The market is segmented in the following ways:
• By Drug Class: Nerve Protective Therapy, Anti-Inflammatory Therapy, Neurotransmitter Based Therapy, Antioxidant, Other Drug Classes.
• By Treatment: Medication, Therapy, Other Treatments.
• By Drug Type: Branded, Generic.
• By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels.
• By End-User: Hospitals, Research Institutes, Specialty Clinics.

Which Region Leads The Chemotherapy Induced Peripheral Neuropathy Treatment Market?
North America was the largest region in the chemotherapy induced peripheral neuropathy treatment market in 2024. The fastest-growing regions are expected to be Asia-Pacific and Europe. The report covers regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-peripheral-neuropathy-treatment-global-market-report

What Is Covered In The Chemotherapy Induced Peripheral Neuropathy Treatment Market Global Market Report?
- Market Size Analysis: Analyze the Chemotherapy Induced Peripheral Neuropathy Treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Chemotherapy Induced Peripheral Neuropathy Treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Chemotherapy Induced Peripheral Neuropathy Treatment Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Chemotherapy Induced Peripheral Neuropathy Treatment Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=11967&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
Learn More About the Business Research Company. With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chemotherapy Induced Peripheral Neuropathy Treatment Market: Size, Growth, Key Players, and Trends through 2025 to 2029 here

News-ID: 3833283 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any